These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9502615

  • 21. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 22. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells.
    Bondza-Kibangou P, Millot C, El Khoury V, Millot JM.
    Oncol Rep; 2007 Dec; 18(6):1513-9. PubMed ID: 17982638
    [Abstract] [Full Text] [Related]

  • 23. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
    Okabe-Kado J, Honma Y, Hayashi M, Hozumi M.
    Anticancer Res; 1991 Dec; 11(1):181-6. PubMed ID: 2018352
    [Abstract] [Full Text] [Related]

  • 24. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
    Maehata Y, Takamizawa S, Ozawa S, Kato Y, Sato S, Kubota E, Hata R.
    Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
    [Abstract] [Full Text] [Related]

  • 25. All natural DR3-type vitamin D response elements show a similar functionality in vitro.
    Toell A, Polly P, Carlberg C.
    Biochem J; 2000 Dec 01; 352 Pt 2(Pt 2):301-9. PubMed ID: 11085922
    [Abstract] [Full Text] [Related]

  • 26. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
    Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S.
    J Immunol; 1998 Jan 01; 160(1):209-18. PubMed ID: 9551973
    [Abstract] [Full Text] [Related]

  • 27. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR.
    J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
    Makishima M, Kanatani Y, Yamamoto-Yamaguchi Y, Honma Y.
    Blood; 1996 Apr 15; 87(8):3384-94. PubMed ID: 8605356
    [Abstract] [Full Text] [Related]

  • 29. Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3.
    Niitsu N, Hayashi Y, Sugita K, Honma Y.
    Br J Haematol; 2001 Feb 15; 112(2):315-26. PubMed ID: 11167824
    [Abstract] [Full Text] [Related]

  • 30. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
    Niitsu N, Umeda M, Honma Y.
    Leuk Res; 2000 Jan 15; 24(1):1-9. PubMed ID: 10634639
    [Abstract] [Full Text] [Related]

  • 31. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
    Danilenko M, Wang X, Studzinski GP.
    J Natl Cancer Inst; 2001 Aug 15; 93(16):1224-33. PubMed ID: 11504768
    [Abstract] [Full Text] [Related]

  • 32. 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells.
    Bastie JN, Balitrand N, Guidez F, Guillemot I, Larghero J, Calabresse C, Chomienne C, Delva L.
    Mol Endocrinol; 2004 Nov 15; 18(11):2685-99. PubMed ID: 15284334
    [Abstract] [Full Text] [Related]

  • 33. Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
    Makishima M, Honma Y.
    Leuk Res; 1996 Sep 15; 20(9):781-9. PubMed ID: 8947589
    [Abstract] [Full Text] [Related]

  • 34. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
    Niitsu N, Umeda M, Honma Y.
    Biochem Biophys Res Commun; 1997 Sep 08; 238(1):100-6. PubMed ID: 9299460
    [Abstract] [Full Text] [Related]

  • 35. Effects of calcitriol on nuclear transcription during human HL-60 promyelocytic leukemia cell differentiation.
    Bresnick EH, Simpson RU.
    Cancer Res; 1986 Oct 08; 46(10):4979-83. PubMed ID: 3463408
    [Abstract] [Full Text] [Related]

  • 36. Effect of butylated hydroxytoluene on bilineage differentiation of the human HL-60 myeloblastic leukemia cell.
    Burns CP, Petersen ES.
    J Cell Physiol; 1990 Jul 08; 144(1):36-41. PubMed ID: 2365744
    [Abstract] [Full Text] [Related]

  • 37. Etoposide stimulates 1,25-dihydroxyvitamin D3 differentiation activity, hormone binding and hormone receptor expression in HL-60 human promyelocytic cells.
    Torres R, Calle C, Aller P, Mata F.
    Mol Cell Biochem; 2000 May 08; 208(1-2):157-62. PubMed ID: 10939640
    [Abstract] [Full Text] [Related]

  • 38. 1α-Dihydroxyvitamin D3 and Retinoic Acid Increase Nuclear Vitamin D Receptor Expression in Monocytic THP-1 Cells.
    Uchida H, Hasegawa Y, Takahashi H, Makishima M.
    Anticancer Res; 2016 Dec 08; 36(12):6297-6301. PubMed ID: 27919949
    [Abstract] [Full Text] [Related]

  • 39. Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13).
    Niitsu N, Hayashi Y, Honma Y.
    Oncogene; 2001 Jan 18; 20(3):375-84. PubMed ID: 11313967
    [Abstract] [Full Text] [Related]

  • 40. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M, Swinnen JV, Heyns W, Verhoeven G.
    Prostate; 1996 Mar 18; 28(3):182-94. PubMed ID: 8628721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.